Since 2020, six of eight community health centers in Rhode Island have seen their revenue from the 340B Drug Discount Program ...

The AHA Feb. 28 filed a friend-of-the-court brief ( in the U.S. District Court for the District of Columbia, urging the court ...

On Wednesday morning, the Nebraska Legislature advanced LB168 which was introduced by state senator Brian Hardin in ...

The pharmaceutical industry and Colorado's hospitals agree that a federal program intended to reduce the cost of outpatient ...

The bill (LB168) from Sen. Brian Hardin of Gering would prohibit drugmakers from restricting the sale of medications included ...

When the 340B program was first launched, pharmaceutical manufacturers were to provide medications at a discounted price for ...

The 340B program requires pharmaceutical companies to sell drugs at a discount to certain health care organizations.

The federal 340B drug pricing program is failing to meet the needs of the vulnerable patients the program was intended to ...

Legislative Bill 168, advanced 41-0, would forbid drugmakers taking part in Medicaid from denying or hindering eligible ...

In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...

The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to ...

Health care in Colorado is at a crisis. Democrats and Republicans fortunately have reached across party lines to solve ...